S2Medical AB (publ) announces conversion of BTU, first day of trading in warrants of series TO 1 and a correction regarding the number of shares
The rights issue of units that was announced on 15 March 2022 (the “Rights Issue”) in S2Medical AB (publ) (the "Company" or "S2Medical") has now been registered with the Swedish Companies Registration Office (Sw. Bolagsverket).
Last day for trading in BTU and first day for trading in warrants of series TO 1
Paid subscribed units (BTU) will be replaced by B shares and warrants of series TO 1. Trading with BTU ended yesterday (23 May 2022) and the stop date with Euroclear Sweden AB will occur on 25 May 2022, whereafter shares and warrants will be booked in each shareholder's VP account/nominee account on 27 May 2022. The warrants will be traded under short name S2M TO 1 B with ISIN code SE0017769433 and the first day of trading is expected to be 30 May 2022.
Number of shares and share capital
The total number of B shares in the Company has increased by 10,536,458 and amounts to 22,463,541 (the total number of shares amounts to 25,588,541). The share capital has increased by SEK 617,177.726560 and amounts to SEK 1,498,860.201441 after registration. If all warrants of series TO 1 are fully exercised, the number of B shares in the Company will increase from 22,463,541 B shares to 32,999,999 B shares (the total number of shares will increase to 36,124,999) and the share capital will increase from SEK 1,498,860.201441 to SEK 2,116,037.928000.
Advisor
Vator Securities AB is acting as financial advisor and Eversheds Sutherland Advokatbyrå AB is acting as legal advisor in connection with the Rights Issue. Vator Securities is also acting as Issuer Agent in connection with the Rights Issue.
Contact Details
Petter Sivlér - CEO, S2Medical AB (publ)
Telephone: +46 (0)8-70 000 50
E-mail: petter.sivler@s2m.se
Certified Adviser
Vator Securities AB
Telephone +46 (0)8-580 065 99
Website: www.vatorsec.se
E-mail: ca@vatorsec.se
The information was submitted for publication, through the agency of the contact person, on 24-05-2022 19:15 CET.
Contact Details
Petter Sivlér – CEO, S2Medical AB (publ)
Telephone: +46 (0)8-70 000 50
E-mail: petter.sivler@s2m.se
Certified Adviser
Vator Securities AB
Telephone +46 (0)8-580 065 99
Website: www.vatorsec.se
E-mail: ca@vatorsec.se
About S2Medical
S2Medical AB (publ) is a medical technology company that develops and sells innovative wound healing products for the entire wound healing process, with a focus on burns and chronic wounds. The company has developed eiratex®, a new cellulose-based material for healing severe burns and chronic wounds. The material heals wounds effectively and thereby reduces both suffering for patients and costs for health care.
Share's ticker: S2M
Share's ISIN-code: SE0011725084